**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 7758-95-4 |Lead (II) chloride | 99.0 | 231-845-5 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T N
Risk Phrases: 20/22 33 61 62 50/53
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation and if swallowed. Danger of cumulative
effects. May cause harm to the unborn child. Possible risk of
impaired fertility. Very toxic to aquatic organisms, may cause
long-term adverse effects in the aquatic environment.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
Causes gastrointestinal irritation with nausea, vomiting and
diarrhea. Ingestion of lead compounds can cause toxic effects in the
blood-forming organs, kidneys and central nervous system.
Inhalation:
May cause respiratory tract irritation. May cause effects similar to
those described for ingestion.
Chronic:
Chronic exposure to lead may result in plumbism which is
characterized by lead line in gum, headache, muscle weakness, mental
changes.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Immediately flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
Antidote:
The use of d-Penicillamine as a chelating agent should be determined
by qualified medical personnel. The use of Dimercaprol or BAL
(British Anti-Lewisite) as a chelating agent should be determined by
qualified medical personnel. The use of Calcium disodium EDTA as a
chelating agent should be determined by qualified medical personnel.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
For small fires, use water spray, dry chemical, carbon dioxide or
chemical foam. Use agent most appropriate to extinguish fire.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Avoid runoff into storm sewers and ditches which lead to
waterways. Clean up spills immediately, observing precautions in the
Protective Equipment section. Sweep up, then place into a suitable
container for disposal. Avoid generating dusty conditions. Provide
ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Avoid contact with
eyes, skin, and clothing. Avoid ingestion and inhalation.
Storage:
Store in a cool, dry place. Keep from contact with oxidizing
materials.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local exhaust ventilation to keep airborne concentrations below the
permissible exposure limits.
Exposure Limits
CAS# 7758-95-4:
United Kingdom, WEL - TWA: (listed as lead compounds): 0.15 mg/m3
(as Pb)
United Kingdom, WEL - STEL: (listed as lead compounds): 0.45 mg/m
TWA (as Pb)
United States OSHA: 50 ??g/m3 TWA (as Pb); 30 ??g/m3 Action Level (
Pb. Poison - see 29 CFR 1910.10 25) (listed under Lead, inorgani
compounds).
Belgium - TWA: (listed as lead, inorganic compounds): 0.15 mg/m3
(dust and fume)
France - VME: (listed as lead compounds): 0.1 mg/m3 VME (as Pb)
Germany: (listed as lead compounds): 0.1 mg/m3 VME (as Pb)
Japan: (listed as lead compounds): 0.1 mg/m3 OEL (except alkyl le
compounds, as Pb)
Malaysia: (listed as lead, inorganic compounds): 0.05 mg/m3 TWA (
Pb)
Netherlands: (listed as lead, inorganic compounds): 0.15 mg/m3 MA
(dust and smoke, as Pb)
Russia: (listed as lead, inorganic compounds): 0.5 mg/m3 TWA (as
Spain: (listed as lead, inorganic compounds): 0.15 mg/m3 VLA-ED (
Pb)
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves and clothing to
prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: white
Odor: odorless
pH: Not available.
Vapor Pressure: 1 mm Hg @547C
Viscosity: Not available.
Boiling Point: 1742 deg F
Freezing/Melting Point: 928-934F
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: 0.99%
Specific Gravity/Density: Not available.
Molecular Formula: PbCl2
Molecular Weight: 278.106
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Strong oxidants.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong acids.
Hazardous Decomposition Products:
Hydrogen chloride, lead/lead oxides.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 7758-95-4: OF9450000
LD50/LC50:
CAS# 7758-95-4: Oral, rat: LD50 = >1947 mg/kg.
Carcinogenicity:
Lead (II) chloride -
California: carcinogen, initial date 10/1/92 (listed as Lead compounds
NTP: Suspect carcinogen (listed as Lead compounds).
IARC: Group 2A carcinogen (listed as Lead, inorganic compounds).
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Products which are considered hazardous for supply are classified as Special
Waste and the disposal of such chemicals is covered by regulations which may
vary according to location. Contact a specialist disposal company or the local
waste regulator for advice. Empty containers must be decontaminated before
returning for recycling.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC SOLID, INORGANIC, NOS(Lead (II) chloride)
Hazard Class: 6.1
UN Number: 3288
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, INORGANIC, NOS(Lead (II) chloride)
Hazard Class: 6.1
UN Number: 3288
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, INORGANIC, NOS(Lead (II) chloride)
Hazard Class: 6.1
UN Number: 3288
Packing group: III
USA RQ: CAS# 7758-95-4: 10 lb final RQ; 4.54 kg final RQ
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T N
Risk Phrases:
R 61 May cause harm to the unborn child.
R 20/22 Harmful by inhalation and if swallowed.
R 33 Danger of cumulative effects.
R 50/53 Very toxic to aquatic organisms, may cause
long-term adverse effects in the aquatic environment.
R 62 Possible risk of impaired fertility.
Safety Phrases:
S 53 Avoid exposure - obtain special instructions
before use.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
S 60 This material and its container must be
disposed of as hazardous waste.
S 61 Avoid release to the environment. Refer to
special instructions/safety data sheets.
WGK (Water Danger/Protection)
CAS# 7758-95-4: No information available.
Canada
CAS# 7758-95-4 is listed on Canada's DSL List.
CAS# 7758-95-4 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7758-95-4 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 12/17/1998 Revision #6 Date: 3/04/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
L-Ascorbic acid
| 50-81-7 |
|
L-Asparagine Monohydrate
| 5794-13-8 |
|
L-Tryptophan
| 73-22-3 |
|
L-Tyrosine
| 60-18-4 |
|
L-Methionine
| 63-68-3 |
|
Methyl 5-oxazolecarboxylate, 96%
| 121432-12-0 |
|
L-Histidine
| 71-00-1 |
|
L-Histidine Hydrochloride Monohydrate
| 5934-29-2 |
|
Cycloheptatriene, 90%
| 544-25-2 |
|
2-Iodobenzyl alcohol, 99%
| 5159-41-1 |
|
5-Chlorovaleryl Chloride, 96%
| 1575-61-7 |
|
2-Nitro-p-phenylenediamine, 95-99%
| 5307-14-2 |
|
1,4-Dioxaspiro[4.5]decan-8-ol, 98+%
| 22428-87-1 |
|
Pyrazino[2,3-f]Quinoxaline, 99+%
| 231-23-2 |
|
Lanthanum chloride heptahydrate
| 10025-84-0 |
|
Lanthanum Oxide
| 1312-81-8 |
|
Lanthanum Nitrate Hexahydrate
| 10099-59-9 |
|
2,3-Pentanedione, 97%
| 600-14-6 |
|
Lauric Acid
| 143-07-7 |
|
Alpha-NPO, Scintillation Grade
| 846-63-9 |
|
4-Benzylpiperidine, 98%
| 31252-42-3 |
|
2-(2-Quinoxalinyl)malondialdehyde
| 0-00-0 |
|
4-Nitro-Benzylthiocyanate, 99%
| 13287-49-5 |
|
Methyl vinyl ketone
| 78-94-4 |
|
Lead
| 7439-92-1 |
|
2-Methoxy-5-nitroaniline, 99%
| 99-59-2 |
|
Methyltriphenylphosphonium iodide, 97%
| 2065-66-9 |
|
Lead(II) acetate trihydrate
| 301-04-2 |
|
4-Ethylbiphenyl-4'-carboxylic acid, 98%
| 5731-13-5 |
|
Mono-(Trimethylsilyl)Phosphite
| 91076-68-5 |
|
N-Acetylanthranilic acid, 99%
| 89-52-1 |
|
1,2,2,6,6-Pentamethylpiperidine, 95% (GC)
| 79-55-0 |
|
Dihydrogentrifluoride Polymer-Supported, ca 7 mMol HF/g of Amberlyst
| 12260-12-7 |
|
Lead (II) Chloride
| 7758-95-4 |
|
Triisopropanolamine borate, 98+%
| 101-00-8 |
|
(S)-3-tert.-Butyl-2,5-piperazinedione
| 65016-62-8 |
|
2-Methoxynaphthalene, 98%
| 93-04-9 |
|
Lead chromate
| 7758-97-6 |
|
1-(2'-Thienyl)Ethylmercaptan, 98%
| 94089-02-8 |
|
4-Bromobenzotrifluoride, 99%
| 402-43-7 |
|
Lead Dioxide
| 1309-60-0 |
|
N-Hydroxymaleimide, 97%
| 4814-74-8 |
|
1-Dodecanethiol, 98.5+% (gc)
| 112-55-0 |
|
2,4,6-Trimethylaniline, 97%
| 88-05-1 |
|
Iodobenzene diacetate, 98%
| 3240-34-4 |
|
Trans 2, cis 6-nonadienol, 94%
| 28069-72-9 |
|
1,5-Dihydroxy-1,2,3,4-Tetrahydro-Naphthalene, Tech.
| 40771-26-4 |
|
Acrolein dimethyl acetal, 99%
| 6044-68-4 |
|
Lead(II) nitrate
| 10099-74-8 |
|
Lead Oxide Yellow
| 1317-36-8 |
|
|